In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Special aspects of postoperative management and frequency of complications of coronary artery bypass surgery in elderly and senile patients with coronary artery disease

Session Poster Session 2

Speaker Tatiana Petrova

Congress : EuroPrevent 2019

  • Topic : preventive cardiology
  • Sub-topic : Secondary Prevention
  • Session type : Poster Session
  • FP Number : P541

Authors : T Petrova (Saint Petersburg,RU), E Lubinskaya (Saint Petersburg,RU), I Zelenskaya (Saint Petersburg,RU), E Demchenko (Saint Petersburg,RU)

15 views

Authors:
T Petrova1 , E Lubinskaya2 , I Zelenskaya2 , E Demchenko2 , 1First Pavlov State Medical University of St. Petersburg - Saint Petersburg - Russian Federation , 2Almazov National Medical Research Centre - Saint Petersburg - Russian Federation ,

Citation:

Background. The rapid ageing of the population is the demographic trend around the world. There is 21,2% elderly and senile of population in the Russian Federation. Cardiovascular diseases, including coronary artery disease (CAD) – are the leading cause of death globally. The number of elderly and senile patients undergoing coronary artery bypass grafting (CABG) is gradually increasing. Information on the incidence of postoperative complications in such patients is contradictory.

Purpose. Assessment of postoperative course and incidence of complications after CABG in elderly and senile patients.

Methods. 120 Russian elderly and senile CAD patients (60-86 y.o., middle age–72,7±10,4 y.o.) undergoing elective On-Pump CABG during 2018 year were enrolled into the trial. We analyzed postoperative course and the incidence of complications.

Results. There were some kinds of postoperative complications in 71,2% cases. Postpericardiotomy syndrome requiring glucocorticosteroids was diagnosed in 13.3% of cases. Postoperative arrhythmias were registered in 39.2% of patients, including new onset paroxysms of atrial fibrillation - in 30%, ventricular arrhythmias - in 9.2%, hemopericardium and re-exploration - in 3.3%, delayed healing of postoperative wounds with the application of secondary sutures - in 3.3%, active infection - in 10.8%, peripheral neuropathies - in 0.8% of patients. Atherosclerotic obstructive brachiocephalic artery lesions were not found according to duplex scanning. However, neurologic complications after CABG are noted in 5,8% patients: perioperative encephalopathy – in 1,7%, stroke verified with multislice spiral CT - in 3.3%, transient ischemic attack (TIA) – in 0,9%. Reduction of cognitive functions according to the MoCA was detected in 70% of patients. Dementia was not detected in any of the patients. The total duration of hospitalisation, associated with the surgery, was 24.8 ± 8.2 days; including 2,6 ± 2,3 days - in the intensive care unit, 5,2 ± 3,3 days - in the cardiosurgery department and 10,1 ± 5,9 days - in the rehabilitation department.

Conclusion. The incidence of postoperative arrhythmias, stroke in elderly and senile patients with CAD is slightly higher than similar data from modern trials performed on younger patients. It requires a detailed analysis with a careful neurological assessment of a larger number of patients. The received results can be used to improve the preparation and postoperative management of elderly and senile CAD patients and to plan the volume of postoperative neurorehabilitation.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are